UBS AM’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-96,811
| Closed | -$525K | – | 2652 |
|
|
2025
Q1 | $525K | Buy |
96,811
+6,462
| +7% | +$35K | ﹤0.01% | 2494 |
|
|
2024
Q4 | $673K | Buy |
90,349
+21,719
| +32% | +$162K | ﹤0.01% | 2497 |
|
|
2024
Q3 | $548K | Sell |
68,630
-10,616
| -13% | -$84.8K | ﹤0.01% | 2617 |
|
|
2024
Q2 | $689K | Buy |
79,246
+69,146
| +685% | +$602K | ﹤0.01% | 2540 |
|
|
2024
Q1 | $209K | Buy |
+10,100
| New | +$209K | ﹤0.01% | 2458 |
|